268 related articles for article (PubMed ID: 28184974)
41. Causes of death among United States decedents with ALS: An eye toward delaying mortality.
Larson TC; Goutman SA; Davis B; Bove FJ; Thakur N; Mehta P
Ann Clin Transl Neurol; 2023 May; 10(5):757-764. PubMed ID: 37000988
[TBL] [Abstract][Full Text] [Related]
42. Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases.
Paulukonis ST; Roberts EM; Valle JP; Collins NN; English PB; Kaye WE
PLoS One; 2015; 10(7):e0131965. PubMed ID: 26172548
[TBL] [Abstract][Full Text] [Related]
43. Amyotrophic Lateral Sclerosis Mortality in the United States, 2011-2014.
Larson TC; Kaye W; Mehta P; Horton DK
Neuroepidemiology; 2018; 51(1-2):96-103. PubMed ID: 29990963
[TBL] [Abstract][Full Text] [Related]
44. Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis.
Capozzo R; Quaranta VN; Pellegrini F; Fontana A; Copetti M; Carratù P; Panza F; Cassano A; Falcone VA; Tortelli R; Cortese R; Simone IL; Resta O; Logroscino G
J Neurol; 2015 Mar; 262(3):593-603. PubMed ID: 25522696
[TBL] [Abstract][Full Text] [Related]
45. Long-term survival in amyotrophic lateral sclerosis: a population-based study.
Pupillo E; Messina P; Logroscino G; Beghi E;
Ann Neurol; 2014 Feb; 75(2):287-97. PubMed ID: 24382602
[TBL] [Abstract][Full Text] [Related]
46. Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies.
Ragonese P; Filippini G; Salemi G; Beghi E; Citterio A; D'Alessandro R; Marini C; Monsurrò MR; Aiello I; Morgante L; Tempestini A; Fratti C; Ragno M; Pugliatti M; Epifanio A; Testa D; Savettieri G
Neuroepidemiology; 2004; 23(1-2):73-7. PubMed ID: 14739571
[TBL] [Abstract][Full Text] [Related]
47. Trends and determinants of end-of-life practices in ALS in the Netherlands.
Maessen M; Veldink JH; Onwuteaka-Philipsen BD; de Vries JM; Wokke JH; van der Wal G; van den Berg LH
Neurology; 2009 Sep; 73(12):954-61. PubMed ID: 19770471
[TBL] [Abstract][Full Text] [Related]
48. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
[TBL] [Abstract][Full Text] [Related]
49. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
[TBL] [Abstract][Full Text] [Related]
50. Establishing a Canadian registry of patients with amyotrophic lateral sclerosis.
Korngut L; Genge A; Johnston M; Benstead T; Bourque P; Briemberg H; Casey A; D'Amour M; Dupré N; Figlewicz D; Hader W; Johnston W; Kalra S; Melanson M; O'Connell C; Rouleau G; Shoesmith C; Wee J; Zinman L
Can J Neurol Sci; 2013 Jan; 40(1):29-35. PubMed ID: 23250124
[TBL] [Abstract][Full Text] [Related]
51. Participation in Physical Activity and Risk for Amyotrophic Lateral Sclerosis Mortality Among Postmenopausal Women.
Eaglehouse YL; Talbott EO; Chang Y; Kuller LH
JAMA Neurol; 2016 Mar; 73(3):329-36. PubMed ID: 26783702
[TBL] [Abstract][Full Text] [Related]
52. Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009-2011 and survival through 2018.
Punjani R; Larson TC; Wagner L; Davis B; Horton DK; Kaye W
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):203-211. PubMed ID: 36200180
[TBL] [Abstract][Full Text] [Related]
53. Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009.
Mehal JM; Holman RC; Schonberger LB; Sejvar JJ
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):346-52. PubMed ID: 23621426
[TBL] [Abstract][Full Text] [Related]
54. The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis.
D'Ovidio F; d'Errico A; Carnà P; Calvo A; Costa G; Chiò A
Eur J Neurol; 2018 Jan; 25(1):164-170. PubMed ID: 28921834
[TBL] [Abstract][Full Text] [Related]
55. Validating population-based registers for ALS: how accurate is death certification?
Yeo L; Lynch C; Hardiman O
J Neurol; 2010 Aug; 257(8):1235-9. PubMed ID: 20151145
[TBL] [Abstract][Full Text] [Related]
56. Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study.
Fasano A; Fini N; Ferraro D; Ferri L; Vinceti M; ; Mandrioli J
Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):233-242. PubMed ID: 28076984
[TBL] [Abstract][Full Text] [Related]
57. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: a meta-analysis.
Cui R; Tuo M; Li P; Zhou C
Neurol Sci; 2018 May; 39(5):811-820. PubMed ID: 29349657
[TBL] [Abstract][Full Text] [Related]
58. Diet and amyotrophic lateral sclerosis.
Morozova N; Weisskopf MG; McCullough ML; Munger KL; Calle EE; Thun MJ; Ascherio A
Epidemiology; 2008 Mar; 19(2):324-37. PubMed ID: 18300717
[TBL] [Abstract][Full Text] [Related]
59. [Changing medical care for amyotrophic lateral sclerosis patients and cause of death - review of muscular dystrophy wards (1999-2013)].
Saito T; Kuru S; Takahashi T; Suzuki M; Ogata K
Rinsho Shinkeigaku; 2021 Mar; 61(3):161-165. PubMed ID: 33627584
[TBL] [Abstract][Full Text] [Related]
60. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort.
Berlowitz DJ; Howard ME; Fiore JF; Vander Hoorn S; O'Donoghue FJ; Westlake J; Smith A; Beer F; Mathers S; Talman P
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):280-6. PubMed ID: 25857659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
